Treatment Action Group (TAG) seeks a consultant to work with its TB team on two grant-specific projects.

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB), the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) and TB Proof hosted a webinar on 16 August 2018 on implementing an injectable-free regimen for drug-resistant TB.

The WHO, Ministries of Health and Finance, donors, implementers, technical assistance providers, civil society, and communities must work together to ensure rapid implementation.

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) will host a webinar on 16 August 2018 at 10 am EDT / 4 pm South Africa / 5 pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB (DR-TB) in light of the new World Health Organization (WHO) policy brief on DR-TB regimens.

TAG’s annual Pipeline Report: Promising new HIV, TB & HCV drugs and diagnostics.

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

July 17, 2018 – Treatment Action Group (TAG) submitted comments to the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) in response to a public request for information (RFI) to inform NIAID's TB Strategic Plan on supporting TB research and development (R&D).

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and DR-TB STAT will host a webinar on 1 August 2018 at 10 am New York / 4pm South Africa / 5pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB.

A TB research briefing for UN Missions in New York City on 4 June 2018 provided an opportunity for discussion on the importance of investing in the full spectrum of TB research, and adopting principles to guide research to ensure efficiency and equitable access. The event featured Dr. Soumya Swaminathan, Deputy Director-General for Programs, World Health Organization, as the keynote speaker and then had three panels.

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.